Is thyroid screening for all pregnant women needed to ensure a healthy pregnancy?
This question was addressed at ENDO 2019 on March 26 in New Orleans.
Screening allows providers to identify individuals at an increased risk of thyroid disease, allowing these individuals to be offered treatment to reduce the risks of disease. Most providers agree that overt thyroid disease needs to be identified and treated during pregnancy to prevent adverse pregnancy outcomes. The debate over whether to screen all pregnant women springs primarily from the unknown clinical implications of subclinical thyroid disease during pregnancy.
Alex Stagnaro-Green, M.D., of the University of Illinois, presented the argument in favor of screening all pregnant women for thyroid disease. Kristien Boelaert, M.D., Ph.D., of the University of Birmingham in the United Kingdom, argued against universal screening. The debate was moderated by Davis S. Cooper, M.D., of Johns Hopkins University.
You can read the full article by Mariah Zebrowski Leach here:
This article by Ben Schwartz explores the benefits of Levothyroxine in the presence of thyroid peroxidase antibodies.
Have a great week!
Are frustrated with the care you are currently receiving but don’t know where to turn, I can help! Check out my Thyroid Testing and Treatment Guide! It will give you the information you need to get your health back! You can get your copy here: The Thyroid Testing and Treatment Guide.